US3711250A - Glucose determination method employing orthotoluidine - Google Patents
Glucose determination method employing orthotoluidine Download PDFInfo
- Publication number
- US3711250A US3711250A US00194682A US3711250DA US3711250A US 3711250 A US3711250 A US 3711250A US 00194682 A US00194682 A US 00194682A US 3711250D A US3711250D A US 3711250DA US 3711250 A US3711250 A US 3711250A
- Authority
- US
- United States
- Prior art keywords
- acid
- reagent
- color
- iron
- glucose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- RNVCVTLRINQCPJ-UHFFFAOYSA-N o-toluidine Chemical compound CC1=CC=CC=C1N RNVCVTLRINQCPJ-UHFFFAOYSA-N 0.000 title abstract description 38
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title abstract description 29
- 239000008103 glucose Substances 0.000 title abstract description 29
- 238000000034 method Methods 0.000 title description 13
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 74
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract description 68
- 239000000203 mixture Substances 0.000 abstract description 63
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 abstract description 36
- 229910052742 iron Inorganic materials 0.000 abstract description 34
- 239000002253 acid Substances 0.000 abstract description 19
- 238000011109 contamination Methods 0.000 abstract description 13
- 235000006408 oxalic acid Nutrition 0.000 abstract description 12
- 239000013060 biological fluid Substances 0.000 abstract description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 30
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 25
- 229960000583 acetic acid Drugs 0.000 description 15
- 239000012362 glacial acetic acid Substances 0.000 description 15
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 14
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 13
- 238000002835 absorbance Methods 0.000 description 13
- 239000004615 ingredient Substances 0.000 description 12
- 229920000137 polyphosphoric acid Polymers 0.000 description 10
- 239000000243 solution Substances 0.000 description 9
- 238000010438 heat treatment Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 6
- 238000012360 testing method Methods 0.000 description 5
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000000356 contaminant Substances 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- -1 cerebrospinal fluid Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229910001447 ferric ion Inorganic materials 0.000 description 1
- 229910001448 ferrous ion Inorganic materials 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
- Y10T436/144444—Glucose
Definitions
- An improved ortho-toluidine reagent composition for use in determination of glucose in biological fluids comprises sufiicient oxalic acid or polyphosphoric acid to provide a uniform intensity of color when the composition is reacted with glucose, independently of contamination with trace amounts of iron.
- ortho-toluidine reagents generally contain from about to about grams per 100 milliliters of ortho-toluidine in glacial acetic acid and often contain a small amount of thiourea usually in a concentration of from about 0.1 to 1 gram per 100 milliliters, to prevent subsequent discoloration of the reagent.
- the reagents may also contain small amounts of hydrazine to provide uniformity in the formation of color with different lots of reagent composition.
- the glucose determination is usually performed on a biological fluid such as serum, plasma or urine; however, Whole blood, cerebrospinal fluid, milk, and other biological fiuids may be analyzed.
- a predetermined volume of sample fluid generally 0.100 milliliter, is mixed with a predetermined volume of ortho-toluidine reagent composition, generally from about 3 to about 5 milliliters, in a suitable container such as a colorimeter cuvette or test tube.
- the mixture is heated to develop color, typically in a heating block at 100 C.
- the amount of color produced in the ortho-toluidine color reaction is drastically reduced by the presence of small amounts of iron.
- Iron may be present in varying amounts as a contaminant in the vials, cuvets, pipets or other glassware used in preparation of the reagent or sample, or it may be introduced as a contaminant in one of the ingredients of the reagent. It may be introduced in varying amounts from water used to wash or rinse labortory glassware. Variations in the degree of iron contamination can bring about undesirable variations in color intensity from lot to lot of reagent composition or from test to test. Both ferric and ferrous iron interfere with the color reaction, and due to the acidic nature of the reagent composition, contact with metallic iron can also result in interference.
- the interference resulting from iron contamination is manifested by decreased final absorbance. Amounts of iron on the order of l to 2 parts per million have been observed to reduce final absorbance by as much as 30 to 50 percent, so that the analytical results are correspondingly decreased. Such interference, if undetected or uncorrected, can thus pose a significant risk of misdiagnosis based on an erroneously low result.
- This invention relates to an improvement in orthotoluidine reagent compositions used for determination of the glucose concentration in biological fluids.
- the invention gives a uniform intensity of color when reacted with a specified quantity of glucose, independently of contamination with small amounts of iron.
- the intensity of color developed in glucose determinations carried out with a conventional ortho-toluidine reagent composition can be made uniform in the presence of iron in the concentrations ordinarily encountered in iron contamination (e.g., from about zero to about three, up to about ten parts by weight of iron per million parts by weight of reagent composition).
- Such uniformity can be provided by the addition of a minor amount of oxalic acid, polyphosphoric acid or a mixture thereof to the reagent composition prior to developing color, and preferably prior to mixing the reagent composition with glucose.
- the addition to the reagent composition of oxalic or polyphosphoric acid in an amount sufiicient to prevent interference by trace amounts of iron provides a reagent composition which gives a consistent uniform absorbance and intensity of color independently of the presence or absence of trace amounts of iron in the ultimate color reaction mixture. Interference is prevented independently of the valence state (ferrous or ferric ion) of the iron contaminant.
- the reagent composition can be formulated with the same ortho-toluidine and glacial acetic acid and with thiourea and hydrazine and other ingredients (if desired) in the same proportions as reagents typically employed, and the glucose determination can be carried out in the identical procedures, with the same proportions of reagent composition and glucose standard or sample as have been heretofore employed, with the sole modification being the addition to the reagent composition of sufiicient of oxalic acid, polyphosphoric acid or a mixture thereof to provide a substantially uniform final absorbance after maximum color development over a range of iron concentrations of from about zero to about one, to about three to about ten parts of iron per million parts of reagent composition.
- the oxalic acid brpolyphosphoric acid ingredient can be added to in formulating the reagent, the reagent composition at any time prior to developing color, for example, immediately before adding a sample or a glucose standard solution, or after such addition but prior to heating to develop color.
- the acid ingredient is preferably added to the other ingredients by parts per million to the maximum expected, generally about 10 parts per million. In general, the final absorbance should appear statistically uniform at the 95 percent confidence level, independently of the presence or absence of iron, the resulting composition will be well protected from interference by iron contamination.
- the oxalic or polyphosphoric acidingredient is generally employed in amounts of from about 0.01 to about 0.05 to about 0.1 to about 0.5 to about 1 gram of acid per 100 milliliters of reagent composition, to saturation of the composition with the acid. It is generally unnecessary to employ the acid ingredient in amounts greater than about one gram per 100 milliliters, and amounts of from about 0.05 to about 0.5 gram per 100 milliliters of final reagent composition are preferred. It is essential, however, that one of the named acid ingredients be employed.
- acids such as ethylenedinitrilotetraacetic acid, malonic acid, succinic acid, adipic acid, maleic acid, phthalic acid, citric acid and phosphoric acid are ineifective in preventing the interference caused by iron contamination.
- the relative proportions of the other ingredients in the reagent composition, and the parameters of the analytical procedure such as proportions of reagent composition and standard or sample, heating time and temperature for color development, wavelength of light at which color intensity is measured, etc. are determined in accordance with known procedures.
- the ortho-toluidine reagent composition and the glucose determination procedure are conventional in the determination of glucose by reaction with ortho-toluidine as the essential color forming reactant.
- the reagent compositioribontains from about 5 to about grams of ortho-toluidine per 100 milliliters of ultimate composition and from about 0.1 to about 1 gram of thiourea per 100 milliliters, the remainder of the composition being glacial acetic acid with the required amount of oxalic or polyphosphoric acid and optionally a small amount of hydrazine added to control the'desired final absorbance.
- a preferred composition contains about 9 grams of ortho-toluidine, 0.5 gram thiourea, 60 to 200 micromoles of hydrazine, and from about 0.01 to 0.5 gram of oxalic or polyphosphoric acid, in glacial acetic acid to obtain a final volume of 100 milliliters.
- Such reagent composition is preferably employed in glucose determination by mixing one part by volume of a biological fluid sample or a glucosestandard solution with about 30 to 50 parts by volume of reagent composition, heating the mixture in a tube in a heating block or water bath at a temperature of about 100 C.
- Example 1 A series of ortho-toluidine reagent compositions is prepared by mixing together the following ingredients in the following proportions:
- Glacial acetic acid q.s. to 100 milliliters.
- o-Toluidine 1 "grams" 9.0 Thiourea do 0.5 10 Oxalic acid do 0.1 Distilled water milliliter 1.0 Glacial acetic acid, q.s. to 100 milliliters.
- Each reagent is tested in duplicate with 0.100 milliliters of an aqueous glucose standard solution containing 100 milligrams of glucose per 100 milliliters.
- Five milliliters of reagent composition are transferred to each of three vials and one vial used as a reagent blank.
- One hundred microliters of the glucose standard is added to each of the two remaining vials. These two vials are capped and the contents mixed well by shaking for about 5 seconds.
- the vials are then placed in a heating block at 100 C. for 7 minutes, after which they are then removed and cooled in a cold water bath for 3 minutes.
- the intensity of the blue-green color given by the glucose standard is then measured at 595 nonometers using a photoelectric colorimeter. (The instrument is previously. adjusted to zero absorbance using the untreated vial of reagent.) The results are set out below.
- Reagent B (2 p.p.m. Fe++ iron) 17. 3
- Reagent C (0.1% oxalic acid plus 2 ppm. 32 D Feiron) 5 31. 8 40 Reagent D (0.1% oxalic acid) p 32. 3
- Example 2 In a similar operation, for reagent compositions E, 50 F, G and H are prepared and tested. The composition of the reagents and the average absorbances obtained are set out below:
- o-To1uidine 9.0% wJv- Thiourea 0.5% w.[v Polyphosphoric acid 0.1% w.[ 33. 5 2,000 ppm. Fe++ iron solution 0.1% vJv Glacial acetic acid Q.s. to 100% by voi Reagent H:
- No'rE.-% wJv. represents percentage in weight by volume correspending to grams per 100 millilters; inlv.” represents percentage by volume.
- Example 3 xalic acid (percent (w./v.)
- a method for determination of glucose comprising the steps of mixing together predetermined quantities of a color forming reagent and a sample composition comprising glucose and developing color in the mixture resulting from both said mixing steps;
- the improvement which comprises the step of adding an acid selected from oxalic acid, polyphosphoric acid and mixtures thereof to the color reagent composition prior to the step of developing color, the acid being added in an amount sufficient to provide a uniform intensity of color which is independent of the presence of trace amounts of iron in said mixture.
- the color reagent composition is prepared by mixing together ortho-toluidine, thiourea, hydrazine and glacial acetic acid in predetermined amounts, and wherein said acid is mixed with the color reagent composition prior to mixing of the reagent composition with the sample.
- a reagent composition useful for determination of glucose by measuring the intensity of color produced by the reaction of glucose with ortho-toluidine, and comprising a solution of ortho-toluidine in glacial acetic acid comprising a solution of ortho-toluidine in glacial acetic acid; the improvement wherein the reagent composition further comprises from about 0.01 gram per 100 milliliters to about saturation of an acid ingredient selected from oxalic acid, polyphosphoric acid and mixtures thereof, whereby said reagent composition is protected from interference by iron contamination.
- composition of claim 6 wherein the composition contains from about 0.05 to about 0.5 gram of said acid ingredient per 100 milliliters of ultimate reagent composition.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19468271A | 1971-11-01 | 1971-11-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US3711250A true US3711250A (en) | 1973-01-16 |
Family
ID=22718519
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US00194682A Expired - Lifetime US3711250A (en) | 1971-11-01 | 1971-11-01 | Glucose determination method employing orthotoluidine |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US3711250A (fr) |
| JP (1) | JPS4853796A (fr) |
| BE (1) | BE790826A (fr) |
| CA (1) | CA961746A (fr) |
| DE (1) | DE2253482A1 (fr) |
| FR (1) | FR2159921A5 (fr) |
| GB (1) | GB1400729A (fr) |
| IT (1) | IT976407B (fr) |
| NL (1) | NL7214723A (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2280082A1 (fr) * | 1974-07-25 | 1976-02-20 | Reveilleau R | Procede pour le dosage de la bilirubine |
| EP0236023A3 (fr) * | 1986-03-03 | 1988-09-07 | Seymour Norman Blackman | Procédé non-enrahissement pour contrôler le taux de glucose-sanguin |
| RU2186370C1 (ru) * | 2000-12-26 | 2002-07-27 | Санкт-Петербургская общественная организация "Невская академия изобретателей" | Способ определения инвертных сахаров |
-
1971
- 1971-11-01 US US00194682A patent/US3711250A/en not_active Expired - Lifetime
-
1972
- 1972-10-20 CA CA154,413A patent/CA961746A/en not_active Expired
- 1972-10-25 GB GB4927572A patent/GB1400729A/en not_active Expired
- 1972-10-30 IT IT53703/72A patent/IT976407B/it active
- 1972-10-30 FR FR7238473A patent/FR2159921A5/fr not_active Expired
- 1972-10-31 NL NL7214723A patent/NL7214723A/xx not_active Application Discontinuation
- 1972-10-31 DE DE2253482A patent/DE2253482A1/de active Pending
- 1972-10-31 BE BE790826A patent/BE790826A/fr unknown
- 1972-11-01 JP JP47108981A patent/JPS4853796A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| FR2159921A5 (fr) | 1973-06-22 |
| GB1400729A (en) | 1975-07-23 |
| CA961746A (en) | 1975-01-28 |
| DE2253482A1 (de) | 1973-05-03 |
| IT976407B (it) | 1974-08-20 |
| NL7214723A (fr) | 1973-05-03 |
| JPS4853796A (fr) | 1973-07-28 |
| BE790826A (fr) | 1973-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kessler et al. | An automated procedure for the simultaneous determination of calcium and phosphorus | |
| Gay et al. | Perchloric acid enhances sensitivity and reproducibility of the ferric–xylenol orange peroxide assay | |
| Kempers | Determination of sub-microquantities of ammonium and nitrates in soils with phenol, sodiumnitroprusside and hypochlorite | |
| US3950226A (en) | Novel reagent and method for the determination of urea in biological fluids | |
| Speakman et al. | Interlaboratory comparison of different analytical techniques for the determination of oxygen-18 abundance | |
| US4282316A (en) | Stabilized enzymic solutions for determining urea | |
| FRIGERIO et al. | A simple method for determination of glutaraldehyde | |
| EP0054096B1 (fr) | Méthode pour la préparation de solutions d'uréase stabilisées | |
| US3934977A (en) | Reagent and method for determining total calcium in body fluids | |
| Smith et al. | Spectrophotometric determination of silicate in natural waters by formation of α-molybdosilicic acid and reduction with a tin (IV)-ascorbic acid-oxalic acid mixture | |
| Momose et al. | Organic analysis—XXIII: Determination of blood sugar and urine sugar with 3: 6-dinitrophthalic acid | |
| US3711250A (en) | Glucose determination method employing orthotoluidine | |
| US20070037289A1 (en) | Method of calibrating the zero point of an apparatus used to determine a quantity of silica using a cororimetric method | |
| Uchida et al. | Determination of twelve elements in botanical samples with inductively coupled plasma atomic emission spectrometry after leaching with tetramethylammonium hydroxide and ethylenediaminetetraacetic acid | |
| US3874853A (en) | Process for determining the concentration of inorganic phosphates in human fluids | |
| US3709662A (en) | Iron analysis reagent formulation | |
| US4040787A (en) | Urea determination of biological fluids using diacetylmonoxime reaction | |
| US3615228A (en) | Glucose determination method employing orthotoluidine | |
| US3718433A (en) | Method of analyzing of ammonia,urea,and tyrosine | |
| CN111239126A (zh) | 用于磷酸盐钼锑抗法测定的检测试剂组合及制备方法 | |
| US3732077A (en) | Method and composition for determining bun | |
| Kamoun et al. | Ultramicromethod for determination of plasma uric acid. | |
| Treybig et al. | Colorimetric determination of total nitrogen in amines with selenium catalyst | |
| Hoch et al. | The Determination of Iodine in Biologic Material | |
| Suzuki et al. | Determination of traces of lead and copper in foods by electrothermal atomic absorption spectrometry with metal atomizer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: SERAGEN DIAGNOSTIC, INC,., 1200 SOUTH MADISON AVEU Free format text: LICENSE;ASSIGNOR:FIRST NATIONAL BANK OF CHICAGO THE;REEL/FRAME:004477/0101 Effective date: 19850913 Owner name: FIRST NATIONAL BANK OF CHICAGO THE, CHICAGO, ILLIN Free format text: SECURITY INTEREST;ASSIGNOR:SERGEN DIAGNOSTICS, INC.;REEL/FRAME:004477/0081 Effective date: 19850913 |